Patents Assigned to Biofocus DPI, Ltd.
  • Substituted imidazo[1,2-a]pyrazine compounds useful for the treatment of viral infections
    Patent number: 8362018
    Abstract: Novel imidazopyrazine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a viral infection, in particular a HCV, HRV, Sb and/or CVB in a patient in need thereof.
    Type: Grant
    Filed: August 20, 2008
    Date of Patent: January 29, 2013
    Assignee: Biofocus DPI, Ltd.
    Inventors: Angus MacLeod, Dale Robert Mitchell, Nicholas John Palmer, Michael Daniel Goldsmith, Clifford John Harris, Christophe Claude Parsy